Research News & Publications

Engineered 'starter key' for brain tumor offers new model for drug testing

06/25/2018

Researchers have applied a new way to trigger medulloblastoma in neural cells that will lead to the ability to test a promising class of anti-tumor drugs.
Researchers develop a better method to compare gene expression in single cells

06/19/2018

Check out a new algorithm that is available at no cost to help researchers get the most out of single-cell RNA sequencing technology.
St. Jude partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers in the United States

06/07/2018

Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers
Rigorous study finds widely used treatment for infection fails young cancer patients

06/05/2018

Study found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and led to more complications.
Pediatric cancer research highlighted at ASCO Annual Meeting

05/31/2018

St. Jude experts share pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.
‘Hidden’ driver discovered that helps prime the anti-tumor immune response

05/30/2018

Read about the algorithm that helped researchers uncover hidden drivers of immune regulation and production of anti-tumor T cells.
St. Jude Children's Research Hospital expands international reach with St. Jude Global

05/24/2018

Hospital invests more than $100 million to improve childhood cancer survival rates worldwide.
St. Jude trial identifies a medulloblastoma subset that requires less aggressive therapy

05/17/2018

For a subset of the youngest patients with the brain tumor medulloblastoma, less aggressive therapy was associated with better long-term survival.
‘Lone wolf’ protein offers new pathway to cancer treatments

05/16/2018

The protein called BOK offers another target for drugs to selectively trigger apoptosis.
St. Jude named the World Health Organization’s first Collaborating Centre for Childhood Cancer

05/16/2018

St. Jude is partnering with WHO to develop strategies that strengthen the global resources, organization and planning needed to identify and treat pediatric cancer.